Indeed, in lung cancer, inhibition of the transforming growth factor-beta (TGF-β) signaling pathway effectively reversed the inhibitory effects of lung cancer exosomes on AMSC adipogenesis[143]. The gene discussed is TGFB1; the disease is lung carcinoma.